Glen is the president and co-founder of Medidata, and the original architect of the Medidata Rave platform. With his deep expertise in medical research and understanding of technology’s role in streamlining complex processes, Glen has been driving Medidata's vision since the company’s inception: Delivering cloud-based solutions to transform the life science industry's approach to bringing new treatments to market.
Glen received his BS in molecular biology and genetics from Carnegie Mellon University, worked as a research scientist at the Columbia Presbyterian Medical Center and studied computer science at New York University's Courant Institute of Mathematics. He is the holder of numerous patents for clinical trial innovations, and is a member of the board of the Young Scientist Foundation and chairman of the board of Dancing Classrooms.
Jim Robinson is President, Astellas Pharma US Inc, a global research-based pharmaceutical company committed to serving unmet medical needs in Oncology, Immunology, Infectious Diseases, Urology, Neuroscience and DM Complications and Kidney Diseases. Jim leads the company’s commercial pharmaceutical operation in the U.S. which spans across a diverse and growing portfolio in the Oncology, Urology, Transplant and Cardiovascular markets. Jim has over 20 years of experience in the pharmaceutical industry. He is a member of Astellas’ Management Committee. Before assuming his present role, Jim was Sr. Vice President for Sales & Marketing and led the company’s expansion into the oncology area. Jim joined Astellas in 2005 as the Vice President of Health Systems responsible for Managed Markets, Reimbursement Strategy, State Government Affairs & Government Accounts. Prior to joining Astellas, he held increasingly more senior marketing and sales positions with Schering-Plough Pharmaceuticals in New Jersey. Jim is a native of Illinois and earned his Bachelor of Science, Marketing at DePaul University in Chicago. He is currently on the board of ChicagoNext which is dedicated to expanding the biotechnology and pharmaceutical presence in Chicago. He lives in the Chicago area with his wife and two daughters.
Jeff Kindler is a healthcare executive, investor and advisor who has held leadership positions at some of the world’s most recognized companies. With more than three decades of experience, Kindler is a leading expert in pharmaceuticals and other health care sectors; corporate legal matters including regulation, litigation, compliance and crisis management; brand and franchise management; board and corporate governance; and executive leadership.
Currently, Kindler serves as CEO of Centrexion Corporation, a privately held biotherapeutics company developing pain therapies; Executive Chairman of vTv, a pharmaceutical development company; Venture Partner at Lux Capital, a leading venture capital firm; Managing Director at Starboard Capital Partners, a private equity firm; and a principal in and advisor to a number of privately held health care firms and sponsors. He is also Global Chair of the GLG Institute, a membership-based learning community for leading executives, and serves as a member of President Obama’s Management Advisory Board.
Kindler serves on the boards of a number of publicly and privately held health care companies as well as several not-for-profit institutions including Tufts University.
Kerry Kennedy is the president of Robert F. Kennedy Human Rights. For more than thirty years, Ms. Kennedy has devoted herself to the pursuit of equal justice, the promotion and protection of basic rights, and the preservation of the rule of law. She has worked on a range of issues, including children’s rights, child labor, disappearances, indigenous land rights, judicial independence, freedom of expression, ethnic violence, impunity, and the environment. She has concentrated specifically on women’s rights, exposing injustices and educating audiences about women’s issues, particularly honor killings, sexual slavery, domestic violence, workplace discrimination, sexual assault, abuse of prisoners, and more. She has led hundreds of human rights delegations. At a time of diminished idealism and growing cynicism about public service, her life and lectures are testaments to the commitment to the basic values of human rights.
Under Ms. Kennedy's leadership, Robert F. Kennedy Human Rights partners with the bravest people on Earth to create lasting change. R.F. Kennedy Human Rights supports defenders in the field with advocacy, litigation, and training; brings human rights to students in the classroom with its innovative Speak Truth To Power curriculum; and engages the financial community about sustainable investing and the intersection between business and human rights.
She is the author of Speak Truth to Power: Human Rights Defenders Who Are Changing Our World, which features interviews with human rights activists including Marian Wright Edelman, the Dalai Lama, and Archbishop Desmond Tutu, and New York Times Best Seller Being Catholic Now. She appears regularly on ABC, NBC, CBS, CNN and PBS as well as on networks in countries around the world, and her commentaries and articles have been published in The Boston Globe, The Chicago Sun-Times, L’Unita, The Los Angeles Times, The Miami Herald, Marie Claire, The New York Times, El Pais, and the Yale Journal of International Law, among others.
Ms. Kennedy served as Chair of the Amnesty International USA Leadership Council for over a decade. Nominated by President Bush and confirmed by the Senate, she serves on the board of directors of the United States Institute of Peace, Human Rights First, HealthEVillages and Inter- Press Service (Rome, Italy). She is a patron of the Bloody Sunday Trust (Northern Ireland) and serves on the Editorial Board of Advisors of the Buffalo Human Rights Law Review. She is on the Advisory Committee for the association of American Indian Affairs; International Campaign for Tibet, the Global Youth Action Network, and several other organizations. She also serves on the Advisory Board of the Albert Schweitzer Institute.
Ms. Kennedy received high honors from President Lech Walesa of Poland for aiding the Solidarity movement. She has received awards from the Southern Christian Leadership Conference, the American Jewish Congress of the Metropolitan Region, the Emerald Isle Immigration Society, and the New York City Council. She was named Woman of the Year 2001 by Save the Children, received the Crossing Borders Award from the Feminist press in 2003, Humanitarian of the Year Award from the South Asian Media Awards Foundation, the Prima Donna Award from Montalcino Vineyards, and other awards and honors in 2008 she received the Eleanor Roosevelt Medal of Honor and the Thomas More Award from Boston College Law School. World Vision and International AIDS Trust gave her the 2009 Human Rights Award. She has also received awards from NYSUT, the American Federation of Teachers, and the National Teachers Association. In 2013 she received the Eleanor Roosevelt Human Rights Award from the Unitarian Universalists.
Ms. Kennedy has served in numerous political campaigns, and she is a member of the Massachusetts and District of Columbia bars. She is a graduate of Brown University and Boston College Law School, and she holds honorary doctorates of law from Le Moyne College, University of San Francisco Law School, and University of New Caledonia, and honorary doctorates of Humane Letters from Bay Path College and the Albany College of Pharmacy.
Ms. Kennedy is the mother of three daughters, Cara, Mariah, and Michaela.
Craig H. Lipset Head of Clinical Innovation Pfizer
Philip Cooksey is responsible for overseeing the execution of Humana’s M&A and joint venture activities, and integration of acquired entities. He has extensive M&A execution and leadership experience with public and private companies and brings broad knowledge of the consumer and healthcare industries. Prior to Humana, he was a VP in the Consumer/Retail/Healthcare Investment Banking division of Goldman Sachs, where he led the development of the e-commerce coverage team, built relationships with key Fortune 100 clients, led the execution of over $50 billion of M&A and capital raising activity, and had a leadership role in talent recruiting and training for his division. Philip holds an MBA in Accounting and Finance from Northwestern University and a bachelor’s degree in Economics and Finance from the University of Louisville.
Katie Trogner Lead Account Executive, Health Twitter
Sarah MacArthur, MD Director of Digital Health Innovation NYU Langone
Stephen Konya joined the U.S. Department of Health and Human Services (HHS), as Senior Innovation Strategist for the Office of the National Coordinator for Health IT (ONC) in the fall of 2015. In addition to developing innovation strategy, he also serves as a key liaison for innovation related projects, and specifically targets engagement opportunities with startups, investors, and the healthcare innovation community at large. Prior to his position with the Federal Government, he served concurrently as Chief of Staff, Chief Operating Officer, and Chief Results Officer for the Illinois Department of Public Health. Where, in addition to many other responsibilities, he was tasked with leading the agency's Innovation and open data strategy, and was appointed Chair of the Open Data Sub-committee under the IL Alliance for Health, a CMMI State Innovation Model (SIM) planning grant. Other assignments included being appointed to the IL Commission on the Elimination of Poverty, and Co-Chair of the Illinois Workforce Investment Board’s (IWIB) Healthcare Taskforce. Previously, Stephen served as the Chief of Staff for the IL Department of Commerce and Economic Opportunity, and CFO of the IL Human Rights Commission. He holds a BBA in Finance and International Business from Loyola University of Chicago, and was both a Fellow and Mentor of the Mid-America Regional Public Health Leadership Institute (MARPHLI) program, at the University of Illinois-Chicago (UIC), School of Public Health.
Lois Drapin, MPS-HSA, founder of The Drapin Group LLC based in NYC, is an experienced advisor, consultant, strategist and business development executive for CEOs, their executive teams and investors in the healthcare, pharmaceutical, digital and mHealth sectors. She is an innovator and technology pioneer in the transformation of how healthcare is delivered, accessed, experienced and perceived by consumers and by healthcare professionals. The bio-psycho-social framework for health and wellness is fundamental to her applied approach in working with healthcare companies. In her role as a growth accelerator for companies, Drapin has and scouted, structured, negotiated and implemented many meaningful product and customer partnerships and distribution models for expansion in current markets and for new market entry. She has worked with companies such as Adidas, UnitedHealthcare, OptumHealth Allies, Johnson & Johnson, Wyeth, Physicians Interactive, Skyscape, WEGO Health, Clinical Care Options, Healthline, Vivometrics (the Life Shirt), Third Age, Happtique, Rip Road and Kognito and dozens of emerging companies. Her healthcare experience covers patient/consumer engagement, behavior change, wearables and sensors, mHealth, women’s health and boomer media, health data, eCME, health insurance, direct-to-consumer health products, market research, social media, contextual targeting, DNA testing, games/gamification solutions and health simulations using emotionally responsive virtual humans. She is a Fellow at the Healthcare Innovation and Technology (HIT) Lab located at Columbia University and listed in Alley Watch’s (NYC, 2014) “The Comprehensive Guide to Who’s Who in NYC e-Health.” Drapin holds an MPS-Health Services Administration degree from The New School in New York and a BA in English from the University of Wisconsin, Madison, WI.
Jean-Luc Neptune Partner, Executive Director & Accelerator Leader Blueprint Health
Jean-Luc (“JL”) Neptune is a licensed physician, entrepreneur, and investor who is currently a partner at Blueprint Health, a leading digital health accelerator. Blueprint Health was founded in 2011 and since its founding has invested in 77 digital health companies of which 85% of still currently operating. Blueprint Health portfolio companies have collectively raised $100mm in funding and in total have an aggregate value of $500mm.
Prior to joining Blueprint Health Jean-Luc was Senior Vice President at Health 2.0 and Director of the Health 2.0 Catalyst program (formerly known as the Developer Challenge program). Through the Catalyst program Health 2.0 has run over 75 innovation competitions and offered over more than $7mm in prizes to a network of thousands of developers, designers and technologists. The Catalyst Platform was the engine behind the ONC "Investing in Innovation" initiative, and has also powered competitions for private sector clients such as the Robert Wood Johnson Foundation, Novartis, Allscripts, and the New York City Economic Development Corporation.
Prior to joining Health 2.0 Jean-Luc co-founded two digital health startups including Healogica, an online clinical trials matching platform (acquired by the Michael J. Fox Foundation), and ExpertConsensus, a virtual second opinion service.
JL earned an BA from Columbia College at Columbia University, an MD from the Columbia College of Physicians and Surgeons, and an MBA at the Wharton School in Philadelphia, focusing on health care and entrepreneurial management and graduating with honors. Jean-Luc completed a residency in internal medicine at Presbyterian Hospital in New York City, passed the ABIM board examination, and is licensed to practice medicine in the state of New York.
Axel Muehlig Manager, Statistical Programming and Analysis, PDBP Roche
Axel Muehlig works at the Roche Innovation Center in NYC. He leads a group of Statistical Programmer Analysts who support the transformation of new molecules into potential new and differentiated medicines through data analytics. Axel has a Masters in Biology from the University of Tuebingen, Germany and has had leadership roles in several FDA filings for new Oncology medicines. He led the development of a tool that is now used globally in harmonized data analysis of Roche and Genentech clinical studies. Axel’s latest passion is the usage of novel analytical tools for a better understanding of disease biology and more targeted therapies. In his free time Axel tends to his orchid collection, watches football of both kinds and enjoys good food.
Lauren McCullagh Assistant Vice President of Clinical Research for the Department of Medicine Service Line Northwell Health
Ms. Lauren McCullagh is the Assistant Vice President of Clinical Research for the Department of Medicine Service Line at Northwell Health. She is a highly qualified and accomplished public health professional with extensive experience implementing public health programs and directing clinical research operations and strategy. She has a diverse educational and professional background, obtaining a Bachelor’s in Medical Science, Honors Biochemistry at the University of Western Ontario, in Canada and starting her career in lab research. She then went on to graduate with a Master's in International Public Health from New York University, has worked at the UN, Doctors without Borders and the Government of Canada. She started her career abroad implementing evidence based projects in the South Africa and Guyana and working to evaluate community HIV prevention programs. Coming back to North America, she continued to work in implementing evidence based programs. While working at Mount Sinai Hospital she worked alongside her mentor, Dr. McGinn to develop, usability testing and study the impact of clinical decision supports (CDS) on provider behavior. She has published extensively on the design and implementation of CDS tools, derivation and validation of clinical prediction models and has focused her research on the longitudinal impact of health IT tools on provider behavior. She currently oversees the Medicine Service line research operations and works with the Northwell venture team on business development with industry sponsors and start-up companies focused.
Dr. Atreja has received formal training in public health and is board certified in gastroenterology, clinical informatics and internal medicine. Over the last fifteen years, he has led many public health and informatics initiatives at Cleveland Clinic and Mount Sinai Medical Center, NY that includes developing online education modules, leading EHR implementation, performing analytics on healthcare data and developing enterprise-wide mobile apps. As Chief Technology Innovation and Engagement Officer, Medicine, he leads the Sinai AppLab (www.sinaiapplab.org) that is one of a kind collaborative hub to build and test disruptive mhealth technologies. Dr. Atreja leads scientific registries for American Gastroenterology Association and serves in Innovation Advisory Board for American College of Cardiology. As an intrapreneur, Dr. Atreja has won innovation awards at Cleveland Clinic and Mount Sinai, successfully licensed technologies from academic centers and advises startups, accelerators and Fortune 500 companies in digital medicine. More recently, Dr. Atreja launched first enterprise-wide app curation and prescribing platform(www.rxuniverse.com) and established Network of Digital Medicine (www.nodehealth.org) to connect innovation centers worldwide and share best practices for digital medicine innovation and implementation. Dr. Atreja has published more than 50 papers and has presented globally on topics related to digital medicine, patient and health system outcomes.
Sunny is a Director at the Partnership Fund for New York City, focusing on Digital Health and Fintech. As part of his role, he leads the NY Digital Health Accelerator, which works collaboratively with growth stage companies and 15 Healthcare Organizations in NY to help develop cutting edge technology products in areas such as care coordination, patient engagement, behavioral health technology, population health and telehealth. Prior to the Partnership Fund, Sunny was Director of Strategy & Finance at RedVision (sold to First American). Previously, Sunny was an Investment Associate at Updata Partners focusing on growth-equity technology investments. Prior to Updata Partners, Sunny worked as an Investment Banking Associate at ThinkEquity Partners. He is a graduate from the Kelley School of Business at Indiana University.
Ruchin Kansal has global experience as an executive, strategic advisor and an entrepreneur in biopharmaceutical and medical devices industry. Trained as an architect, he brings human centered design thinking to the world of business. He is adept at launching & maturing new businesses and capabilities; and driving large scale transformation programs. Currently, he serves as the Head, Business Innovation at Boehringer Ingelheim Pharmaceuticals, Inc. In this role, he is responsible for incubating the development and evolution of strategic capabilities that adapt Boehringer Ingelheim’s business to changing market environment. In addition to establishing company’s first Business Innovation team, he has concurrently launched company’s first Organized Customer Collaborations team, first Digital Health team, and developed its first Patient Engagement Strategy. He is a 2016 recipient of MM&M’s Top 40 Healthcare Transformers Award; invited by the White House Office of Science and Technology Policy (OSTP) for a workshop on engaging participants as partners in research, a core principle of the President’s Precision Medicine Initiative; and also winner of Boehringer Ingelheim President’s Award for establishing company’s first Patient Engagement Vision and Strategy. He serves on the Board of Directors of Stanford Medicine X initiative.
Prior to Boehringer Ingelheim, he worked at Deloitte Consulting and Cap Gemini Ernst & Young . He holds an undergraduate degree in Architecture from Indian Institute of Technology (IIT), Roorkee and MBA from NYU-Stern.
Steve Berman is Montefiore IT’s (MIT – for profit subsidiary of Montefiore Health System) Director of Business Development. He plays a key role in creating new technology partnerships with acute care hospitals and integrated delivery networks in the NY Metro area. Primarily those relationships are providing data center and managed services for our cadre of clients. He is also leading the effort evaluating new start-up technologies for the Medical Center. Approximately 300 – 400 companies are presented to Montefiore per year and Berman will vet the companies; assessing the viability of the company, determining if the solution solves a clinical need or problem, meets strategic direction of the medical center, evaluating the competitive landscape in the market place in order to consider a pilot opportunity. Berman is also involved in structuring and negotiating the business terms for these relationships. Mr. Berman is a Business Mentor for the HITLAB Healthcare Innovation Lab, Blueprint Health LLC, Junto Health, NYeC and the NYCEDC. Berman is also a guest lecturer at Seton Hall University.
Mr. Berman joined MIT in 2008 from Advanced Monitored Caregiving (AMC), where he served as executive vice president. In this role, he was responsible for designing sales, marketing and business processes that resulted in large engagements for telehealth systems with major health systems. Mr. Berman’s career spans over 20 years in key financial and managerial positions at Merrill Lynch, Chemical Bank and Touche Ross, designing innovative business strategies that deliver tangible benefits to clients.
Berman is a Certified Public Accountant and received an M.B.A. from the University of Virginia, Darden School of Business. He graduated with distinction with a bachelor’s degree in business administration from Boston University.
Dr. Adamian is a Managing Partner of Azimuth Ventures, a venture fund focused on early stage healthcare-centric opportunities.
She is also the Founder and Executive Director of Life Sciences Angel Network (predecessor of Azimuth Ventures) focused on the early stage investing in medical devices, healthcare information technology and services as well as educational activities for entrepreneurs and investors.
Milena brings unique perspective of a clinician and academic researcher with genuine passion for breakthrough technologies enriched by industry knowledge, Wall Street, and venture capital experience. In last 20 years, her career included professional appointments at Interventional Cardiology department (Lenox Hill Hospital (NYC) and Columbus Hospital (Milan, Italy), Medical Director at Boston Scientific Corporation (NYSE: BSC), Equity analyst (Medical Devices and Supplies) at Lehman Brothers and Managing Director, Easton Capital.
Dr. Adamian’s past and present investments and board involvements include Xoft (now NYSE: ICAD), Cardiovascular Systems (now NYSE: CSII), Forge Medical, Precise Light Surgical, Quartzy, Comprehend Systems, ZappRX, Common Sensing, BioTrace Medical, Avhana Health, ZestHealth, Wellframe, Owlet Care, and Lifecode Health
Milena is actively involved in a number of accelerators and angel groups across the US.
Milena Adamian was named to the TechWeek100 list of leaders in NYC area with significant impact in business and technology and was named among 2014 – Women of Influence Honoree 2015 by New York Business Journal.
Dr. Adamian is a member of the American College of Cardiology and is also an author of a number of scientific peer-reviewed papers.
She holds an MSc degree in Biostatistics and Clinical Research Methods from Mailman School of Public Health at Columbia University, and MD and PhD degrees in Clinical Cardiology from the Russian Academy of Medical Sciences.
Dr. Ray Dorsey is David M. Levy Professor of Neurology and Director of the CHET at the University of Rochester Medical Center. Dr. Dorsey is helping investigate new treatments for movement disorders and improve the way care is delivered for individuals with Parkinson disease and other neurological disorders. Using simple web-based video conferencing, he and his colleagues are seeking to provide care to individuals with Parkinson and neurological diseases anywhere that they live.
Dr. Dorsey previously directed the movement disorders division and neurology telemedicine at Johns Hopkins and worked as a consultant for McKinsey & Company. He completed his undergraduate studies at Stanford University, medical school at the University of Pennsylvania, and business school at the Wharton School. Dr. Dorsey's research has been published in the leading medical, neurology, and economic journals and has been featured on National Public Radio, The New York Times, and The Wall Street Journal.
David Silk Senior Account Executive, Healthcare Google
David is a Senior Partner Lead in Google's Healthcare Vertical. David partners with some of the world largest healthcare companies to help them improve their digital marketing efforts. David has over 15 years of healthcare experience - focused exclusively in the pharmaceutical, biotechnology, and medical device space. Prior to Google, David spent 5 years at Pfizer, where he held a number of strategy and marketing roles - and lead a team charged with digitizing Pfizer's US marketing efforts.
Dominic S. Haazen Lead Health Policy Specialist World Bank
Dominic S. Haazen is a Lead Health Policy Specialist with the Health Nutrition and Population Global Practice of the World Bank, based in Washington, D.C., where he works on a variety of projects related to health reform, health financing, health system management, and emergency medical services, with specific focus and expertise in health management information systems/e-Health, where he has worked in almost 30 countries. Overall, he has worked in close to 60 countries, and has had field assignments in Dar es Salaam, Tanzania (2008-2011), and Riga, Latvia (2002-2004). Prior to joining the Bank in 1998, he worked as a private consultant in the areas of health financing, health planning, and operational reviews of health providers, and held senior positions in the British Columbia (Canada) Ministry of Health, including Director of Health Economics and Planning, Executive Director of the division responsible for funding hospitals and long-term care, and Executive Director of the B.C. Ambulance Service (a province-wide emergency medical services provider). He holds a B.Sc. degree in Mathematics/Computer Science and a Master in Public Administration from the University of Victoria (Canada) and is a Chartered Professional Accountant.
Michael Frost MD is one of only 1,400 board certified addiction medicine specialists in North America. He is a physician who is board certified in both Addiction Medicine and Internal Medicine and is a Certified Medical Review Officer. This places Dr. Frost in a unique capacity to heal patients suffering from addiction from a holistic approach.
Dr. Frost completed his residency training at Drexel University College of Medicine in Philadelphia PA. Currently, Dr. Frost serves as Director of Internal Medicine Services at The Horsham Clinic, a behavioral healthcare facility, located in Ambler, PA. He is also an Assistant Professor of Family, Community, and Preventive Medicine at Drexel University College of Medicine. He has presented at the national level and has been a consultant to clients across North America. His professional interests include educating both the public and professionals about the diseases of addiction and advocating for addiction treatment.
Jeremy Sohn VP, Global Head of Digital Business Development Novartis
JEREMY BLOCK is the Managing Partner of Venture Catalyst, working with investors and venture-backed companies to maximize the odds of venture success. Dr. Block is also an adjunct professor of public and international affairs at Baruch College. Jeremy is currently the executive director of a digital health trial focusing on population screening of genetic founder mutations at Memorial Sloan Kettering Cancer Center. Previously, Dr. Block was an Assistant Professor of Population Health Science & Policy at the Icahn School of Medicine at Mount Sinai where he was also an IRB Chair at hospitals within the Mount Sinai Health System. Jeremy is primarily interested in the intersection of science and technology with society, public policy, and business. His background includes advising at the federal, state, and local level on a variety of science and technology relevant fields include; green procurement, human research subject protections, chemical & biological weapons, emerging properties and markets with science and technology components, and research systems at public & private universities. In addition Jeremy has been involved in technology development in the areas of virtual reality and also digital & mobile health applications. He has a background in teaching ethics in public policy, bioethics, and science and technology policy at both the undergraduate and graduate level.
He holds a Bachelors in Chemistry & Biology, Masters in Public Policy, and Ph.D. in Biochemistry from Duke University.
Rachel Sha Vice President, Central Transactions and Digital Business Development Sanofi
Dr. Lebret is a consultant, academic physician and advisor in digital health who's goal is to improve medical outcomes with the judicious use of technology. He is Assistant Professor of Medicine at NYU School of Medicine and President, Lebret Consulting. He also is the Medical Director for Clinical Analytics at CloudMedx - healthcare AI platform, a HITLAB Scholar and sits on the advisory board for the NYC EDC's Digital Health Breakthrough Network and continues to see patients. He maintains relationships with Google, Cornell Tech, Mount Sinai, Columbia, Northwell, Montefiore, Pfizer, NYC Department of Health, US Department of Health and Human Services, New York Academy of Sciences, Accenture, Sharecare, the New York Times, CityMD, Blueprint Health, IBM-Watson, UCSF, Stanford, Harvard, Aetna, MedicineX, Health 2.0, One Medical and Kaiser Permanente and numerous startups. He has been quoted in Forbes, Medscape, Fierce Health IT, MedPage Today, Beckers Hospital Review, Good Magazine, Monster.com and the Huffington Post. @JimLebret • linkedin.com/in/jimlebret • lebretconsulting.com
Robert H. Reiner PhD BCN BCB, Executive Director and founder of Behavioral Associates (BA), has been practicing psychology since 1981. After receiving his undergraduate degree at the University of Pennsylvania, he went on to get his Ph. D. in clinical psychology at the University of Alabama and serve his clinical internship at Bellevue Hospital. Dr. Reiner can frequently be seen and quoted in the news and media and is often called upon to make appearances on major news networks for his expert opinion. Throughout his career he has served as psychological consultant for several corporations as well as an expert witness for a number of criminal trials. He is well known for his work in treating anxiety and phobias through biofeedback and virtual reality therapy. He has been credited for this work in articles in the Wall Street Journal, New York Times, New York Daily News, USA Today, Newsweek and Time Out magazine. He has specifically had great success in treating patients for fear of flying which was documented on an episode of The National Geographic Show featuring Dr. Reiner’s work with a phobic patient. He is a co-author of, The Fearless Smile Overcoming Dental Phobia, a book on the subject of people suffering from dental phobias and how they can be effectively treated. The book, published in Jan. 2012 was written by Dr. Reiner along with two well-known Manhattan dentists. Dr. Reiner currently serves on the Ethics Board at the International Society for Neurofeedback and Research (ISNR) and teaches neurofeedback certification courses on a regular basis. He served on the faculty at NYU Medical Center, Dept. of Psychiatry, from 1980 to 2015 and is a guest lecturer at the University of Pennsylvania psychology department.
Rick Lee has made a career in the creation and sales of specialty health care applications and services sold to employers and health plans. He was one of the early architects of the managed mental health (1982) and disease management (1994) industries. He is the founder and former CEO of Healthrageous, a behavioral change company launched in 2009 by Partners HealthCare, sold to Humana in September 2013. In June, he led a investor group spinning out MeYou Health from Healthways (HWAY) and now serves as CEO of that digital engagement platform firm in Boston.
Mr. Lee was the President of Employer Solutions, a $125 million Employee Assistance division of Magellan Health Services (NYSE:MGLN) from 2006-2008. He founded Quality Oncology, a cancer disease management firm, in 1995 and was instrumental in the company’s growth and ultimate sale to Matria Healthcare in 2003. In the late ‘80s, he was part of the founding team of Value Health, Inc. a specialty managed care company that grew to a $1.5 billion IPO in 3 ½ years.
Rick is a graduate of Harvard College and the University of Washington School of Public Health, where he received an M.H.A.
Oren Frank is the Co-Founder and CEO of Talkspace. Founded in 2012, Talkspace's vision is to make Psychotherapy accessible and affordable for a billion people in need around the world. Talkspace is a B2C company that developed "Unlimited Messaging Therapy", a new modality that removes all the major barriers to entry to outpatient mental health. Over 350,000 users have already used Talkspace.
Stan is one of America’s distinguished scholars in healthcare information policy and management, having taught e-health and healthcare e-business for nearly 20 years. He has authored over 100 scholarly papers and presentations for the world’s leading journals and societies in healthcare technology management, informatics and e-governance. In 1996 he was elected to the US-based College of Healthcare Information Management Executives. In 2003 he was elected as a Fellow in the Royal Society of Medicine in the United Kingdom for his research with the National Health Service in using handhelds to track patient data. Stan is currently a Visiting Professor at the Indian Institute of Technology, New Delhi, India, while also overseeing all programmatic activities at HITLAB.
Nishita joined HITLAB in 2006. As the executive director of HITLAB, Nishita leads the organization through its fast-paced growth and helps the organization excel beyond industry standards. Over the course of her career, Nishita has worked for small and large organizations, entrepreneurs and students to achieve individual and organizational effectiveness and growth. At HITLAB she oversees human resources and organization development activities, as well as operations and co-leads strategy, marketing and communications with the Research Chair. Her previous work experience spans across India and the United States where she has been part of human resources and organization development apparatus in various capacities. Nishita has a PhD in Social and Organizational Psychology from Columbia University. She also has a Masters in Philosophy from the same program, a Masters in Organizational Psychology from Teachers College, Columbia University and a Masters in Applied Psychology from the University of Delhi, India, where she graduated summa cum laude from the program. Her primary research interests include cross cultural dynamics and employee engagement.
Laura Pugliese Deputy Director, Innovation Research HITLAB
As Deputy Director of Innovation Research, Laura leads HITLAB's mHealth and digital health research efforts. This includes conceptualizing, implementing and evaluating projects to improve healthcare worldwide. She brings a global perspective and a passion for strategizing innovative, stylish and resourceful solutions to pressing healthcare problems.
Laura has studied, worked and traveled around the world, including in over a dozen African countries. Before joining HITLAB, Laura provided qualitative research and strategic consulting for Oxfam and International Medical Corps, and led grants, new media and institutional development efforts for a non-profit working to expand education access in Cape Town, South Africa. She has also worked with Boston University School of Public Health to perform exploratory investigation of remote technology-driven solutions for disaster relief, and led award-winning independent qualitative research on patient-provider relationships in South Africa’s women’s health services.
Laura holds a bachelor’s degree from Georgetown University and a Master in Public Health from Boston University.
Frank Fries Director, Information Technology and Product Development HITLAB
As Director of Information Technology and Product Development, Frank Fries plays both an internal and an external facing role at HITLAB. He steers internal IT projects, ensuring that IT services are in place to support HITLAB staff and initiatives. He also works with customers and vendors to guide projects and products through their full lifecycles (conception, development, release and maintenance).
Frank arrived at HITLAB with more than 20 of IT experience. His background includes software development, network and system administration, project management, and IT management in Honolulu, New York, and Kenya.
Previously, Frank served as IT Director for an East Harlem, New York City non-profit where he managed the IT implementation of a new, 65,000 square foot building for a K-8 charter school. Prior to his work in East Harlem, he spent three years working to improve IT service operations for a large healthcare program in Western Kenya. Frank’s projects in Kenya included deploying a large-scale, wireless wide area network to link a number of health centers across the western region.
Sabra Bhat Manager, Collaborations, Alliances, and Partnerships HITLAB
Sabra’s primary role at HITLAB is Manager for all collaborations, alliances, and partnerships that HITLAB has with various key stakeholders in healthcare. She also contributes her skills in strategy, research, and evaluation to a number of HITLAB projects.
Before HITLAB, Sabra worked for the NYC Department of Health, UNDP, and Mercy Corps, from which she developed her commitment to global health issues, particularly in sexual and reproductive health. She spent 3+ years in the field addressing healthcare challenges in low-income and often politically volatile regions in India-Administered Kashmir, Pakistan, Peru, and the Dominican Republic. Her exposure to digital technology interventions while working for Mercy Corps in India-Administered Kashmir propelled her into the world of digital health and innovation.
Sabra received her BA in Anthropology from Bryn Mawr College, a Seven-Sister Ivy, and her MPA from Columbia University’s School of International and Public Affairs.
Sara joins HITLAB after spending five years at New York University’s Langone Medical Center promoting patient and family centered care in its neonatal intensive care population. As a senior family advisor at the Sala Institute for Patient and Family Centered Care, she currently serves on a variety of quality and safety committees at NYU Langone, representing the key perspective of patients and families.
Before beginning her work in the field of patient and family centered care, Sara completed postdoctoral research fellowships at both Hunter College and Columbia University, where she conducted research related to mental health treatment and stigma as part of the Psychiatric Epidemiology Training Program in the Department of Epidemiology at Columbia’s Mailman School of Public Health.
Prior to finishing her doctoral studies in Sociomedical Sciences at Columbia’s Mailman School, Sara worked in a variety of settings conducting research and quality improvement work related to mental health services at the New York City Department of Health and Mental Hygiene and the Louis de la Parte Mental Health Institute at the University of South Florida. While working at USF, she also spent two years teaching as an adjunct professor of sociology at the University of Tampa.
Sara holds an MSPH in social and behavioral sciences applied to health from the University of South Florida’s College of Public Health and a bachelor’s degree in sociology from New College of Florida.
Margaret Griffin Manager, Innovation Research HITLAB
Meg is rejoining HITLAB team after furthering her studies at Columbia University’s Mailman School of Public Health and working across Southeast Asia implementing mHealth interventions and championing digital health efforts for reproductive health and other neglected health issues. She consulted with the Population Council, Bangladesh to strategically engage key stakeholders as a means of garnering support and enthusiasm for woman’s health in the region. She has extensive experience conceptualizing, implementing, and evaluating health IT research, programing, and interventions worldwide. She brings a passion for strategic innovation, collaborate thinking, and an entrepreneurial perspective to find solutions for pressing health problems.
Her previous work at HITLAB included managing, developing, supporting, and implementing health technology research. Meg managed several studies including an activity study aimed at improving fall detection devices for elderly populations, co-authoring several publications. She has experience writing research protocols, working through the IRB process, recruiting subjects, and coordinating programmatic efforts. She was an essential grant development team member helping the Lab successfully win several grants. Meg has presented Lab research to the United Nations, the NIH, APHA, mHealth Summit, and other health IT conferences. She is also the co-inventor on several health IT and mHealth patents.
Meg attended Fordham University where she received numerous awards in both leadership and community service.
Molly Woodriff Manager, Innovation Research HITLAB
As a Manager at HITLAB, Molly develops and implements research at the intersection of health and technology. Many of her projects at HITLAB have focused on evaluating innovative healthcare solutions and delivering high quality mixed methods research to clients interested in improving healthcare around the globe. Molly is not afraid to let go of the status quo, and she brings a creative, academically rigorous approach to research methodologies and design.
Prior to joining HITLAB, Molly conducted original ethnographic research on innovative approaches to psychiatric care for a New York City Department of Health and Mental Hygiene pilot project. She also conducted mobile health cancer research at the University of Virginia as well as tracked and photographed health and housing issues affecting flood-displaced populations in Cartagena, Colombia.
Molly received her Master of Public Health from Columbia University and her B.A. with distinction in Bioethics from the University of Virginia.